Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Boehringer Ingelheim
Fuji
Chinese Patent Office
Johnson and Johnson
Harvard Business School
Fish and Richardson
US Army
Julphar

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 012151

« Back to Dashboard

NDA 012151 describes ALDACTONE, which is a drug marketed by Gd Searle Llc and is included in one NDA. It is available from two suppliers. Additional details are available on the ALDACTONE profile page.

The generic ingredient in ALDACTONE is spironolactone. There are fifteen drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the spironolactone profile page.
Summary for 012151
Tradename:ALDACTONE
Applicant:Gd Searle Llc
Ingredient:spironolactone
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 012151
Mechanism of ActionAldosterone Antagonists
Medical Subject Heading (MeSH) Categories for 012151
Suppliers and Packaging for NDA: 012151
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALDACTONE spironolactone TABLET;ORAL 012151 NDA G.D. Searle LLC Division of Pfizer Inc 0025-1001 N 0025-1001-31
ALDACTONE spironolactone TABLET;ORAL 012151 NDA G.D. Searle LLC Division of Pfizer Inc 0025-1031 N 0025-1031-31

Profile for product number 008

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Dec 30, 1982TE:ABRLD:Yes

Profile for product number 009

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Dec 30, 1983TE:ABRLD:Yes

Profile for product number 010

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Dec 30, 1983TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Chubb
Medtronic
Harvard Business School
QuintilesIMS
Argus Health
Queensland Health
US Army
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.